97 related articles for article (PubMed ID: 25545052)
1. Hydroxyurea-induced stomatocytes in a patient presenting with polycythemia vera.
Perrin J; Ranta D; Lesesve JF
Am J Hematol; 2015 Jun; 90(6):573. PubMed ID: 25545052
[No Abstract] [Full Text] [Related]
2. Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia.
Ricksten A; Palmqvist L; Johansson P; Andreasson B
Haematologica; 2008 Aug; 93(8):1260-1. PubMed ID: 18519514
[No Abstract] [Full Text] [Related]
3. Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy.
Girodon F; Schaeffer C; Cleyrat C; Mounier M; Lafont I; Santos FD; Duval A; Maynadié M; Hermouet S
Haematologica; 2008 Nov; 93(11):1723-7. PubMed ID: 18728027
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
[No Abstract] [Full Text] [Related]
5. How safe is hydroxyurea in the treatment of polycythemia vera?
Haematologica; 1999 Aug; 84(8):673-4. PubMed ID: 10457399
[No Abstract] [Full Text] [Related]
6. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
Tefferi A; Elliott MA; Kao PC; Yoon S; El-Hemaidi I; Pearson TC
Blood; 2000 Aug; 96(4):1582-4. PubMed ID: 10942409
[TBL] [Abstract][Full Text] [Related]
7. Polycythemia vera with pancytopenia and red cell fragmentation.
Hsia CC; Xenocostas A
Blood; 2011 Nov; 118(18):4769. PubMed ID: 22167863
[No Abstract] [Full Text] [Related]
8. Hydroxyurea-associated acral erythema in a patient with polycythemia vera.
Butler D; Nambudiri VE; Nandi T
Am J Hematol; 2014 Sep; 89(9):931-2. PubMed ID: 24585573
[No Abstract] [Full Text] [Related]
9. Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera.
França ER; Teixeira MA; Matias Kde F; Antunes DE; Braz Rde A; Silva CE
An Bras Dermatol; 2011; 86(4):751-4. PubMed ID: 21987143
[TBL] [Abstract][Full Text] [Related]
10. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
Ellis AK; Lee DH
Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
[No Abstract] [Full Text] [Related]
11. Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea.
Alvarez-Larrán A; Díaz-González A; Such E; Mora E; Andrade-Campos M; García-Hernández C; Gómez-Casares MT; García-Gutiérrez V; Carreño-Tarragona G; Garrote M; Fernández-Ibarrondo L; Cervera J; Bellosillo B; Cervantes F; Hernández-Boluda JC;
Leukemia; 2021 Feb; 35(2):623-627. PubMed ID: 32372025
[No Abstract] [Full Text] [Related]
12. Treatment of polycythemia vera with hydroxyurea.
Gebbia V; Bonaccorso R; Tambone Reyes M; Di Salvo V; Di Marco P; Citarrella P
J Chemother; 1989 Jul; 1(4 Suppl):1278-80. PubMed ID: 16312865
[No Abstract] [Full Text] [Related]
13. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
[TBL] [Abstract][Full Text] [Related]
14. Observations with 5-hydroxyurea in the management of polycythaemia vera.
Nagy G; Szegedi J; Petrányi G
Ther Hung; 1972; 20(3):91-5. PubMed ID: 4652145
[No Abstract] [Full Text] [Related]
15. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Touahri T
Am J Hematol; 1996 Nov; 53(3):207-8. PubMed ID: 8895700
[No Abstract] [Full Text] [Related]
16. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
17. [Unilateral internal cerebral vein thrombosis in MRI].
Wittkugel O; Lange R; Fiehler J
Rofo; 2004 Feb; 176(2):259-61. PubMed ID: 14872383
[No Abstract] [Full Text] [Related]
18. Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients.
Spanoudakis E; Bazdiara I; Kotsianidis I; Margaritis D; Goutzouvelidis A; Christoforidou A; Tsatalas C; Bourikas G
Ann Hematol; 2009 Jul; 88(7):629-32. PubMed ID: 19096846
[TBL] [Abstract][Full Text] [Related]
19. [Hydroxyurea in the treatment of erythremia].
Demidova AV
Ter Arkh; 1993; 65(9):82-4. PubMed ID: 8303607
[No Abstract] [Full Text] [Related]
20. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
